US Patent Issued to MedImmune on Sept. 30 for "Combination therapies using anti-pseudomonas PSL and PCRV binding molecules" (British, American Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,473, issued on Sept. 30, was assigned to MedImmune Ltd. (Cambridge, Great Britain).

"Combination therapies using anti-pseudomonas PSL and PCRV binding molecules" was invented by Antonio Digiandomenico (Gaithersburg, Md.), Paul Warrener (Gaithersburg, Md.), Charles Stover (Gaithersburg, Md.), Bret Sellman (Gaithersburg, Md.), Ralph Minter (Cambridge, Great Britain), Sandrine Guillard (Cambridge, Great Britain), Steven Rust (Cambridge, Great Britain), Mladen Tomich (Exton, Pa.), Vignesh Venkatraman (Cambridge, Great Britain), Reena Varkey (Gaithersburg, Md.), Li Peng (Gaithersburg, Md.), Melissa Damschroder (Gaithersburg, Md.), Partha S. Chowdhury (Gaithersburg, Md.), Nazzareno Dim...